- US12594244utility2026Therapeutic Compositions for Treatment of Human Immunodeficiency Virus0 cites
- US12594267utility2026Capsid Inhibitors for the Treatment of HIV0 cites
- US12590062utility2026PD-1/PD-L1 Inhibitors0 cites
- US12590089utility2026Processes for Preparing Toll-like Receptor Modulator Compounds0 cites
- USD1118367design2026Blister Pack0 cites
- US12570662utility2026Substituted Pyrrolo[1,2-b]pyridazines as Bifunctional Degraders of Interleukin-1 Receptor-associated Kinases0 cites
- US12570642utility2026GLP-IR Modulating Compounds0 cites
- US12559546utility2026Methods of Identifying HIV Patients Sensitive to Therapy with Gp120 CD4 Binding Site-directed Antibodies0 cites
- US12559553utility2026IL-31 Modulators for Treating Fxr-induced Pruritus0 cites
- US12528814utility2026Bifunctional Degraders of Interleukin-1 Receptor-associated Kinases and Therapeutic Use Thereof0 cites
- US12509466utility2025Methods and Compounds for Treating Paramyxoviridae Virus Infections0 cites
- US12503454utility2025LPA Receptor Antagonists and Uses Thereof0 cites
- US12497382utility2025GLP-1R Modulating Compounds0 cites
- US12497408utility2025Tetracyclic Compounds and Methods for the Treatment of Zika Virus Infection0 cites
- US12492189utility2025Solid Forms of an HIV Capsid Inhibitor0 cites
- US12486252utility2025Solid Forms of a Cot Inhibitor Compound0 cites
- US12486271utility2025Solid Forms of a Toll-like Receptor Modulator0 cites
- US12479853utility2025HIV Inhibitor Compounds0 cites
- US12473271utility2025GLP-1R Modulating Compounds0 cites
Page 1 of 11Next →